tm
Seeing Is Believing
tm
Seeing Is Believing
AQST is currently covered by 6 analysts with an average potential upside of $7.57 (119.09%) backed by displayed 9 price targets and 36 ratings.
Analysts average stock forecasts to be materialized ratio is 3.13% with an average time for these price targets to be met of 6.5 days.
Highest price target for AQST is 3, Lowest price target is 1, average price target is 2.
Most recent stock forecast was given by ANDREAS ARGYRIDES from WEDBUSH on 10-Oct-2023. First documented stock forecast 31-Aug-2018.
Currently, out of the existing stock ratings of AQST - 10 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
1 months 20 days ago
0/1 (0%)
$1.39 (86.34%)
Buy
5
$3.47 (226.80%)
5
2 months 8 days ago
0/7 (0%)
$3.64 (179.85%)
Buy
2 months 9 days ago
0/1 (0%)
$14.65 (89.60%)
Buy
10
$8.46 (549.35%)
5 months 30 days ago
0/1 (0%)
$7.69 (332.90%)
Buy
1 years 6 months 12 days ago
0/4 (0%)
$4.64 (76.54%)
What is AQST (Aquestive Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?
Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?
Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?
